Market research on the consumer health industry. Our reports feat...
Market research on the consumer health industry. Our reports feature a wealth of standardised and cross-comparable statistics including total market sizes, market share and share data, distribution and industry trends.
Consumers have been returning to doctors’ surgeries in the post-pandemic landscape, thus hindering the sales of OTC medicines which they are instead accessing via prescription. This is noted to be the case with antihistamines, for example, along with…
With value sales of cough and cold and allergy ( hay fever) remedies reducing to more normal levels. as concern about COVID-19 abate, there is expected to be a decline in volume sales in 2023. The exception being medicated confectionery. Along with…
Retail sales of dermatologicals saw a second year of healthy growth in constant value terms in 2023. The category suffered a decline during the pandemic, when consumers spent more time at home and were therefore less exposed to environments which…
With society operating normally once again, after the pandemic, visits to doctors in relation to skin conditions have increased. This is seeing products such as topical antifungals, vaginal antifungals, cold sore treatments, and haemorrhoid…
Dermatologicals is set to maintain a healthy growth trajectory in current value terms in Brazil in 2023, in line with the increase recorded in 2022, driven mainly by price rises. The pandemic years were marked by a reduction in Brazilians’ purchasing…
Dermatologicals maintain a healthy growth trajectory in line with figures recorded in 2022, retaining significant value sales that surpass pre-pandemic levels. While this category typically demonstrates notable stability and does not exhibit…
Dermatologicals is expected to see higher value growth in 2023 than in the previous year. Value growth is partly being driven by escalating prices and partly by people returning to in-person medical consultations, which lead to more recommendations…
As consumers face stress due to economic uncertainty and skin imbalances after COVID-19, many suffer from hair loss, helping category growth. While some consumers opt for dietary supplements to avoid hair loss, others turn to shampoos or other…
Despite the challenging economic conditions affecting the country, consumers continue to purchase a variety of dermatological products as awareness about treating certain conditions increases. Categories such as haemorrhoid treatments, medicated…
Medicated shampoo is expected to register the highest current value growth in dermatologicals in 2023, with the big winner being Genommalab’s Medicasp. This brand has significantly increased value share over the review period. With substantial…